| A high prevalence of hereditary alpha-tryptasemia in pediatric mastocytoma M Madrange, J Rossignol, C Devin, L Bekel, N Bellon, A Welfringer-Morin, ... Allergy, 2024 | | 2024 |
| Répartition des sérotypes de vaccins pneumococciques contenus dans le vaccin dans les pneumonies communautaires nécessitant une hospitalisation chez l'adulte en France LB Luong, X Duval, E Botelho-Nevers, F Lainé, R Hernu, E Blanc, ... Médecine et Maladies Infectieuses Formation 3 (2), S129, 2024 | | 2024 |
| Décčs et ré-hospitalisation dans les 30 mois suivant une hospitalisation pour Covid-19: étude exposé/non-exposé ā partir du SNDS M Rontani, S Tubiana, X Duval, P Herlemont, R Dray-Spira, M Zureik, ... Médecine et Maladies Infectieuses Formation 3 (2), S26, 2024 | | 2024 |
| Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial A Dinh, C Duran, J Ropers, F Bouchand, L Deconinck, M Matt, O Senard, ... Clinical Microbiology and Infection, 2024 | | 2024 |
| Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection A Marchal, ET Cirulli, I Neveux, E Bellos, RS Thwaites, KMS Barrett, ... Human Genetics and Genomics Advances, 2024 | | 2024 |
| Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial V Terzić, J Miantezila Basilua, N Billard, L de Gastines, D Belhadi, ... Clinical Infectious Diseases, ciae170, 2024 | 1 | 2024 |
| Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases C D’humières, M Delavy, L Alla, F Ichou, E Gauliard, A Ghozlane, ... Microbiome 12 (1), 50, 2024 | | 2024 |
| Décès et ré-hospitalisation dans les 30 mois suivant une hospitalisation pour COVID-19: étude exposé/non-exposé à partir du Système national des données de santé (SNDS) M Rontani, S Tubiana, X Duval, R Dray-Spira, M Zureik, A Weill, C Burdet Journal of Epidemiology and Population Health 72, 202261, 2024 | | 2024 |
| Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China M Chen, Y Ma, H Chen, J Dai, L Dong, M Jia Journal of Infection 88 (3), 2024 | | 2024 |
| Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial M Hites, CR Massonnaud, EL Lapique, D Belhadi, S Jamard, ... Journal of Infection 88 (3), 2024 | | 2024 |
| Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials II Siempos, AC Kalil, D Belhadi, VC Veiga, AB Cavalcanti, ... EClinicalMedicine 69, 2024 | | 2024 |
| Comparison of clinical metagenomics with 16S rDNA Sanger sequencing for the bacteriological diagnosis of culture-negative samples C d'Humieres, S Haviari, M Petitjean, L Deconinck, S Gueye, ... medRxiv, 2024.06. 18.24309080, 2024 | | 2024 |
| Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes L Polivka, M Madrange, C Bulai-Livideanu, S Barete, T Ballul, A Neuraz, ... Journal of Allergy and Clinical Immunology 153 (1), 349-353. e4, 2024 | 5 | 2024 |
| Lack of association between HLA and asymptomatic SARS-CoV-2 infection A Marchal, ET Cirulli, I Neveux, E Bellos, RS Thwaites, KMS Barrett, ... medRxiv, 2023 | 2 | 2023 |
| RWD27 Opportunities and Challenges in Linkage of Early Access Databases With the French National Claims Database: A RWE Effectiveness Study of AZD7442 for Pre-Exposure … L Luong, AS Jannot, C Burdet, L Majed, C Fabry-Vendrand, T Cerceau, ... Value in Health 26 (12), S509, 2023 | | 2023 |
| Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial C Sylvie, B Lila, D Claire, B Charles, T Jean-François, N Beldjoudi, ... Annals of Intensive Care 13 (1), 75, 2023 | | 2023 |
| Association between SARS‐CoV‐2 viral kinetics and clinical score evolution in hospitalized patients N Néant, G Lingas, A Gaymard, D Belhadi, M Hites, T Staub, R Greil, ... CPT: Pharmacometrics & Systems Pharmacology 12 (12), 2027-2037, 2023 | 2 | 2023 |
| Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial S Chevret, L Bouadma, C Dupuis, C Burdet, JF Timsit Annals of Intensive Care 13 (1), 75, 2023 | 2 | 2023 |
| An elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes: Pathophysiological implications L Polivka, M Madrange, C Bulai-Livideanu, S Barete, T Ballul, A Neuraz, ... J. Allergy Clin. Immunol 10, 2023 | 1 | 2023 |
| The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans J Burgaya, J Marin, G Royer, B Condamine, B Gachet, O Clermont, ... PLoS Genetics 19 (8), e1010842, 2023 | 5 | 2023 |
